Skip to main content
logo
USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
18.03
-0.10 (-0.55%)
Jun 5, 2026, 4:00 PM EDT - Market closed

USANA Health Sciences Cash Flow Statement

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Net Income
9.1511.4842.0663.7969.35116.51
Depreciation & Amortization
39.2539.722.2320.421.4122.19
Stock-Based Compensation
14.413.8314.5614.613.3314.3
Other Adjustments
-5.710.42-4.85-0.14-0.961.29
Change in Receivables
-5.37-----
Changes in Inventories
-23.17-34.69-2.122.3515.8-14.7
Changes in Accounts Payable
1.775.2-1.27-0.43-2.66-4.57
Changes in Other Operating Activities
-20.68-13.6-9.62-29.92-12.37-13.79
Operating Cash Flow
16.6322.3560.9970.64103.9121.23
Operating Cash Flow Growth
-71.72%-63.36%-13.66%-32.01%-14.29%-24.42%
Capital Expenditures
-13.67-13.82-10.07-14.49-10.4-12.76
Sale of Property, Plant & Equipment
3.953.910.060.020.010.02
Payments for Business Acquisitions
---203.34--6.53-
Other Investing Activities
1.4-0.210.262.54.56-1.44
Investing Cash Flow
-8.85-10.13-213.09-11.98-12.37-14.19
Short-Term Debt Issued
21.617.623.691.5411-
Short-Term Debt Repaid
-30.6-26.6-1.47-0.75-11-
Net Short-Term Debt Issued (Repaid)
-9-922.220.790-
Repurchase of Common Stock
-15.21-27.51-9.44-11.6-25.38-177.84
Net Common Stock Issued (Repurchased)
-15.21-27.51-9.44-11.6-25.38-177.84
Other Financing Activities
-5.57-4.1-3.22-3.43-4.71-3.58
Financing Cash Flow
-29.78-40.69.55-14.24-30.09-181.41
Effect of Exchange Rate Changes on Cash and Cash Equivalents
5.295.11-6.19-2.5-13.782.09
Net Cash Flow
-16.71-23.27-148.7441.9347.67-72.28
Free Cash Flow
2.968.5350.9256.1593.5108.46
Free Cash Flow Growth
-65.27%-83.26%-9.31%-39.95%-13.79%-25.36%
FCF Margin
0.32%0.92%5.96%6.10%9.36%9.14%
Free Cash Flow Per Share
0.160.462.662.904.845.33
Levered Free Cash Flow
-16.62-15.4463.442.4881.1392.88
Unlevered Free Cash Flow
-8.4-6.8535.6935.8580.4992.57
SEC Filings: 10-K · 10-Q